SXTP
$2.29+0.04 (+1.61%)
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.
Intraday
Recent News
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) is one of the best up and coming penny stocks to buy. On February 2, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to enhance the affordability and accessibility of ARAKODA (tafenoquine), the only FDA-approved, once-weekly prescription medication for malaria prevention in the US. The collaboration allows eligible patients to […]
Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy?
In February 2026, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to offer eligible U.S. consumers savings of up to 30% on ARAKODA, the only FDA-approved, once-weekly prescription malaria prevention, across more than 70,000 pharmacies and home delivery where available. This collaboration broadens GoodRx’s presence in travel-related preventive care, linking its discount platform to a specialized medication for malaria risk management. Next, we’ll examine how expanding into...
Sector Update: Health Care Stocks Mixed Late Afternoon
Health care stocks were mixed late Thursday afternoon, with the NYSE Health Care Index up 0.2% and t
Top Midday Gainers
60 Degrees Pharmaceuticals (SXTP) reported Thursday a partnership with Runway Health to boost access
Sector Update: Health Care Stocks Rise in Afternoon Trading
Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index and the State Street